Search results for " pulmonary disease"

showing 10 items of 137 documents

Coexistence of frailty syndrome and the level of health behaviors in elderly patients with chronic obstructive pulmonary disease

2023

Wprowadzenie: Przyspieszenie tempa starzenia się populacji, związane z tym ryzyko występowania zespołu słabości oraz wzrost liczby osób żyjących z przewlekłą obturacyjną chorobą płuc (POChP) powodują, że przyszłe kierunki polityki zdrowotnej powinny się skupiać na działaniach z zakresu promocji zdrowia, potęgowaniu zachowań prozdrowotnych, utrzymaniu lub poprawie sprawności funkcjonalnej starzejących się ludzi. Cel pracy: Analiza współwystępowania zespołu kruchości oraz nasilenia zachowań zdrowotnych u pacjentów w wieku podeszłym z POChP, jak również ustalenie czynników determinujących nasilenie zachowań zdrowotnych. Materiał i metody: Zbadano 100 pacjentów z rozpoznaniem POChP (średnia wie…

health behaviorstarzenie sięagingfrailtyprzewlekła obturacyjna choroba płuczespół słabościzachowania zdrowotnechronic obstructive pulmonary diseaseStudia Medyczne
researchProduct

Comorbidities and clinical outcomes of a lung cancer screening trial participants with chronic obstructive pulmonary disease in three-year follow-up

2022

To improve the effectiveness of lung cancer screening using low-dose computed tomography (LDCT), the presence of smoking-related comorbidities that may significantly affect mortality in this group should be taken into account. Material and methods: A questionnaire survey and spirometry tests were conducted in a group of 730 respondents as part of a lung cancer screening study between 2016 and 2018. People diagnosed with COPD underwent a three-year follow-up to assess the incidence of medical events. Results: Our study confirmed that cardiovascular diseases (CVDs) were the most common comorbidities in patients who were diagnosed with COPD and participated in LDCT lung cancer screening. Among…

lung cancerscreeningoncologydiagnostic radiologyGeneral Medicinerespiratory tractchronic obstructive pulmonary diseaseEuropean Journal of Translational and Clinical Medicine
researchProduct

Noninvasive Ventilation in Critically Ill Patients

2015

Since its first application in the late 1980s, noninvasive ventilation (NIV) has been the first-line intervention for certain forms of acute respiratory failure. NIV may be delivered through the patient's mouth, nose, or both using noninvasive intermittent positive pressure ventilation or continuous positive airway pressure. When applied appropriately, NIV may reduce morbidity and mortality and may avert iatrogenic complications and infections associated with invasive mechanical ventilation. This article provides physicians and respiratory therapists with a comprehensive, practical guideline for using NIV in critical care. © 2015 Elsevier Inc.

lung diseaseproceduremedicine.medical_treatmenttreatment indicationtreatment contraindicationReviewCritical Care and Intensive Care MedicineAcute respiratory failureintensive care unitequipment designContinuous positive airway pressureHospital MortalityRespiratory systemNoserisk reductionsleep disorderemergency health serviceRespiratory Distress Syndromeemergency wardcritical illnehumidifierGeneral Medicineadult respiratory distress syndromeIntermittent positive pressure ventilationCritically patientrespiratory circuitmedicine.anatomical_structurepriority journalpositive end expiratory pressureNoninvasive ventilationEmergency Service Hospitalmedicine.medical_specialtyventilatorCritical Illnesswardhypercapnic nonchronic obstructive pulmonary diseasecritically ill patientRespiratory Distress Syndrome Adult Critical Illneobesity hypoventilation syndromemedicineHumansAcute respiratory failurehumanIntensive care medicinelung edemaMechanical ventilationgeneral wardhypoxemiaNoninvasive Ventilationair humidificationCritically illbusiness.industrypractice guidelineRespiratory Distress Syndrome Adultneurally adjusted ventilator assistrespiratory intensive care unitmortalityacute cardiogenic pulmonary edemahypercapnic chronic obstructive pulmonary diseasedisease exacerbationnoninvasive positive pressure ventilationbusinesschronic obstructive lung diseaserespiratory therapeutic device
researchProduct

Expertise préalable à la création d’un tableau de maladie professionnelle ou à l’élaboration de recommandations aux comités régionaux dereconnaissanc…

2022

Le plan d’actions sur les produits phytopharmaceutiques publié en avril 2018 vise notamment, sur la base des recommandations formulées par l’Inspection générale des affaires sociales, l’Inspection générale des finances et le Conseil général de l’alimentation, de l’agriculture etdes espaces ruraux dans leur rapport conjoint de janvier 2018, à améliorer la prise en charge des maladies professionnelles liées aux pesticides.Dans ce cadre, les pouvoirs publics ont, par courrier en date du 24 avril 2018, saisi l’Institut national de la santé et de la recherche médicale (Inserm) afin d’actualiser l’expertise collective « Pesticides : effets sur la santé » parue en 2013. Cette expertise synthétise …

medical diagnosis[SDV]Life Sciences [q-bio]causal relationshipreconnaissanceOccupational diseaseoccupational exposurepesticidesMaladie professionnellechronic obstructive pulmonary diseasecompensationexposition professionnelle[SDV] Life Sciences [q-bio]diagnostic médical[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBronchopneumopathie chronique obstructive[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologierelation causale
researchProduct

Impact of domestic mould exposure on Aspergillus biomarkers and lung function in patients with chronic obstructive pulmonary disease

2021

International audience; Patients with chronic obstructive pulmonary disease (COPD) are frequently colonised or sensitised by Aspergillus, but clinical significance remains unclear. Furthermore, little is known on the impact of indoor mould exposure during COPD. In this study, we assessed the relationship between domestic mould exposure, Aspergillus biomarkers and COPD severity during acute exacerbation and at stable state. Aspergillus section Fumigati culture in sputum and anti-Aspergillus antibodies detection (IgG and precipitins) were followed up in COPD patients that were prospectively recruited during exacerbation (n = 62), and underwent a visit at stable state after 18 months (n = 33).…

medicine.medical_specialtyExacerbationMESH: Pulmonary Disease Chronic Obstructive010501 environmental sciencesEnvironmentMESH: Forced Expiratory VolumeAspergillosis01 natural sciencesBiochemistryGastroenterologyPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineanti-Aspergillus antibodiesForced Expiratory VolumeInternal medicinemedicineAspergillosisHumansCOPDClinical significanceMESH: Lung030212 general & internal medicineMESH: AspergillosisLungLung function0105 earth and related environmental sciencesGeneral Environmental Science[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthCOPDAspergillusMESH: Humansbiologybusiness.industryFungimedicine.diseasebiology.organism_classificationrespiratory tract diseasesAspergillusMESH: Aspergillusbiology.proteinMESH: BiomarkersSputummedicine.symptomAntibodybusinessBiomarkers
researchProduct

Inspiratory muscle training combined with pursed lip technique in women with chronic osbtructive pulmonary disease: a case study.

2020

Objective. To improve pulmonary function, exercise capacity and quality of life of two women with Chronic Obstructive Pulmonary Disease (COPD). Material and Methods. Study of two clinical cases, both women. An intervention of 8 weeks was performed, in which the patients performed 3 weekly sessions, of which 1 was performed with supervision of the physiotherapist and 2 sessions were performed at home. The treatment sessions consisted of inspiratory muscle training with an inspiratory threshold and controlled breathing exercises with the pursed lip technique. Results. Quality of life of both women improved at the end of the study. In the woman with severe COPD, Maximal Inspiratory Pressure (M…

medicine.medical_specialtyFisioteràpiaAerospace EngineeringPulmonary diseaseSevere copdchronic obstructive pulmonary diseasePulmonary function testinglcsh:GV557-1198.995Quality of lifeMedicinelcsh:Sports medicinepursed liplcsh:SportsCOPDinspiratory muscle trainingControlled breathingbusiness.industryInspiratory muscle trainingExercise capacitymedicine.diseaserespiratory tract diseasesrespiratory physiotherapyPhysical therapylcsh:RC1200-1245businessPulmons Malalties
researchProduct

Fusion of the 1H NMR data of serum, urine and exhaled breath condensate in order to discriminate chronic obstructive pulmonary disease and obstructiv…

2015

Chronic obstructive pulmonary disease, COPD, affects the condition of the entire human organism and causes multiple comorbidities. Pathological lung changes lead to quantitative changes in the composition of the metabolites in different body fluids. The obstructive sleep apnea syndrome, OSAS, occurs in conjunction with chronic obstructive pulmonary disease in about 10–20 % of individuals who have COPD. Both conditions share the same comorbidities and this makes differentiating them difficult. The aim of this study was to investigate whether it is possible to diagnose a patient with either COPD or the OSA syndrome using a set of selected metabolites and to determine whether the metabolites t…

medicine.medical_specialtyPathology(COPD)Endocrinology Diabetes and MetabolismMetaboliteClinical BiochemistryChronic obstructive pulmonary disease (COPD)Urinediscriminant modelsBiochemistryGastroenterologychronic obstructive pulmonary diseasechemistry.chemical_compoundNMR spectroscopyInternal medicinePartial least squares regressionMedicineExhaled breath condensatePathologicalCOPDLungbusiness.industrymedicine.diseasechemometricsrespiratory tract diseasesObstructive sleep apneamedicine.anatomical_structurechemistrybusinessobstructive sleep apnea syndrome (OSAS)Metabolomics
researchProduct

Osteoporosis in men: a case report

2010

Osteoporosis in men is frequently not considered, underdiagnosed and often undertreated. In contrast with osteoporosis occurring in women, the genesis is frequently secondary (30-60%) with a complex diagnostic approach. A careful anamnesis and physical examination associated with laboratory and instrumental evaluation are necessary for an accurate diagnosis. The clinical case presented concerns a 70-year-old man with negative family history for osteoporosis and a personal history of depression, HBV carrier, and chronic obstructive pulmonary disease (COPD) in a heavy ex-smoker with history of alcoholism. The comprehensive geriatric evaluation allowed us to diagnose a multifactorially seconda…

medicine.medical_specialtyPediatricsAlcohol abuseOsteoporosisMedicine (miscellaneous)Alcohol abusePhysical examinationMale osteoporosis; Alcohol abuse; Osteomalacia; Malnutrition; Chronic obstructive pulmonary diseaseMedicineMale osteoporosisFamily historyDepression (differential diagnoses)COPDOsteomalacialcsh:R5-920medicine.diagnostic_testbusiness.industryChronic obstructive pulmonary diseaseMalnutritionmedicine.diseaseOsteomalaciaPhysical therapyBusiness Management and Accounting (miscellaneous)Secondary osteoporosisClinical Medicinebusinesslcsh:Medicine (General)Clinical Management Issues
researchProduct

How to manage aspergillosis in non-neutropenic intensive care unit patients.

2014

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level …

medicine.medical_specialtyPediatricsChronic ObstructiveAntifungal AgentsCritical IllnessPopulationPulmonary diseaseSettore MED/41 - AnestesiologiaReviewNeutropeniaOpportunistic InfectionsAspergillosisCritical Care and Intensive Care MedicineCommunicable DiseasesCommunicable Diseases Emerginglaw.inventionPulmonary DiseaseImmunocompromised HostPulmonary Disease Chronic ObstructiveAspergillosis non-neutropenic ICUlawAdrenal Cortex HormonesRisk FactorsEpidemiologymedicinenon-neutropenicPrevalenceAspergillosisHumansIntensive care medicineeducationEmergingeducation.field_of_studybusiness.industryIncidence (epidemiology)Medicine (all)IncidenceAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicinemedicine.diseasePrognosisIntensive care unitAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised HostIntensive Care UnitsCohortICUAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicine; Medicine (all)businesssepsis aspergillosis icu managementCritical care (London, England)
researchProduct

Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis

2018

Fulvio Braido,1 Pierachille Santus,2 Angelo Guido Corsico,3 Fabiano Di Marco,4 Giovanni Melioli,5 Nicola Scichilone,6 Paolo Solidoro7 1Department of Internal Medicine, IRCCS San Martino di Genova University Hospital, Genoa, Italy; 2Department of Biomedical and Clinical Sciences, University of Milan, Division of Respiratory Diseases, “L. Sacco” University Hospital, ASST Fatebenefratelli-Sacco, Milan, Italy; 3Department of Internal Medicine and Therapeutics, Division of Respiratory Diseases, IRCCS Policlinico San Matteo Foundation, University of Pavia, Italy; 4Department of Health Sciences, University of Milan, San Paolo Hospital, Milan, Italy; 5Center for Precision Medici…

medicine.medical_specialtyValidation studyConcordance analysisbusiness.industryGeneral MedicinePrimary careInternational Journal of Chronic Obstructive Pulmonary Diseasemedicine.diseasecomputer.software_genreObstructive lung diseaseExpert system03 medical and health sciences0302 clinical medicine030228 respiratory systemSample size determinationConcomitantEmergency medicinemedicine030212 general & internal medicineMedical diagnosisbusinesscomputerInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct